tradingkey.logo
tradingkey.logo
Search

Soleno Therapeutics Says Death Of Patient Not Related To VYKAT XR Treatment

ReutersSep 10, 2025 6:40 PM
facebooktwitterlinkedin

- Soleno Therapeutics Inc SLNO.O:

  • SOLENO THERAPEUTICS INC - AWARE OF SERIOUS ADVERSE EVENT IN FDA'S FAERS REGARDING PATIENT WHO DIED - SEC FILING

  • SOLENO THERAPEUTICS INC - CASE REPORTED AS NOT RELATED TO VYKAT XR TREATMENT - SEC FILING

  • SOLENO THERAPEUTICS INC - PATIENT WAS A 17-YEAR-OLD MALE WHO DIED FROM PULMONARY EMBOLUS - SEC FILING

  • SOLENO THERAPEUTICS INC - VYKAT XR HAS PROVEN SAFETY AND EFFICACY PROFILE - SEC FILING

Source text: [ID:n0001193125-25-199882]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI